Comerica Bank’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $306K | Sell |
31,814
-414
| -1% | -$4.28K | ﹤0.01% | 2099 |
|
|
2025
Q3 | $393K | Buy |
+32,228
| New | +$339K | ﹤0.01% | 2002 |
|
|
2025
Q2 | – | Sell |
-1,168
| Closed | -$8.48K | – | 3769 |
|
|
2025
Q1 | $8.48K | Sell |
1,168
-3
| -0.3% | -$22 | ﹤0.01% | 3206 |
|
|
2024
Q4 | $8.07K | Buy |
1,171
+938
| +403% | +$6.45K | ﹤0.01% | 3219 |
|
|
2024
Q3 | $1.72K | Sell |
233
-18,947
| -99% | -$177K | ﹤0.01% | 3521 |
|
|
2024
Q2 | $202K | Sell |
19,180
-2,031
| -10% | -$25.7K | ﹤0.01% | 2262 |
|
|
2024
Q1 | $293K | Sell |
21,211
-4,572
| -18% | -$71.4K | ﹤0.01% | 2125 |
|
|
2023
Q4 | $501K | Buy |
25,783
+1,840
| +8% | +$34K | ﹤0.01% | 1857 |
|
|
2023
Q3 | $508K | Buy |
+23,943
| New | +$622K | ﹤0.01% | 1786 |
|
|
2022
Q4 | $1.25M | Buy |
29,746
+6,612
| +29% | +$254K | 0.01% | 1341 |
|
|
2022
Q3 | $847K | Sell |
23,134
-325
| -1% | -$13.5K | 0.01% | 1545 |
|
|
2022
Q2 | $999K | Sell |
23,459
-25
| -0.1% | -$1.15K | 0.01% | 1527 |
|
|
2022
Q1 | $1.15M | Buy |
23,484
+311
| +1% | +$15.4K | 0.01% | 1508 |
|
|
2021
Q4 | $1.14M | Sell |
23,173
-72
| -0.3% | -$3.2K | 0.01% | 1498 |
|
|
2021
Q3 | $955K | Sell |
23,245
-4,587
| -16% | -$232K | 0.01% | 1708 |
|
|
2021
Q2 | $1.41M | Sell |
27,832
-1,074
| -4% | -$61.1K | 0.01% | 1534 |
|
|
2021
Q1 | $1.56M | Sell |
28,906
-1,818
| -6% | -$99K | 0.01% | 1514 |
|
|
2020
Q4 | $1.78M | Sell |
30,724
-1,059
| -3% | -$55.7K | 0.01% | 1376 |
|
|
2020
Q3 | $1.7M | Sell |
31,783
-616
| -2% | -$29.2K | 0.01% | 1252 |
|
|
2020
Q2 | $1.47M | Sell |
32,399
-41
| -0.1% | -$1.32K | 0.01% | 1275 |
|
|
2020
Q1 | $854K | Buy |
32,440
+35
| +0.1% | +$1.05K | 0.01% | 1448 |
|
|
2019
Q4 | $1.11M | Buy |
32,405
+160
| +0.5% | +$6.53K | 0.01% | 1495 |
|
|
2019
Q3 | $1.43M | Buy |
32,245
+57
| +0.2% | +$2.39K | 0.01% | 1315 |
|
|
2019
Q2 | $1.25M | Sell |
32,188
-3,550
| -10% | -$181K | 0.01% | 1392 |
|
|
2019
Q1 | $1.85M | Sell |
35,738
-645
| -2% | -$39.1K | 0.02% | 1175 |
|
|
2018
Q4 | $2.29M | Buy |
36,383
+560
| +2% | +$37.8K | 0.02% | 1010 |
|
|
2018
Q3 | $2.51M | Sell |
35,823
-6,726
| -16% | -$534K | 0.02% | 972 |
|
|
2018
Q2 | $3.24M | Buy |
42,549
+3,249
| +8% | +$252K | 0.02% | 930 |
|
|
2018
Q1 | $2.79M | Sell |
39,300
-833
| -2% | -$59.1K | 0.02% | 1025 |
|
|
2017
Q4 | $2.94M | Buy |
40,133
+54
| +0.1% | +$3.49K | 0.02% | 1019 |
|
|
2017
Q3 | $2.53M | Buy |
40,079
+99
| +0.2% | +$6.08K | 0.02% | 1066 |
|
|
2017
Q2 | $2.59M | Buy |
39,980
+574
| +1% | +$32.7K | 0.02% | 1027 |
|
|
2017
Q1 | $2.17M | Buy |
+39,406
| New | +$2.03M | 0.02% | 1164 |
|
|
2014
Q2 | – | Sell |
-5,864
| Closed | -$486K | – | 2179 |
|
|
2014
Q1 | $486K | Buy |
5,864
+11
| +0.2% | +$966 | ﹤0.01% | 1878 |
|
|
2013
Q4 | $809K | Sell |
5,853
-3,938
| -40% | -$464K | 0.01% | 1660 |
|
|
2013
Q3 | $938K | Sell |
9,791
-5,236
| -35% | -$444K | 0.01% | 1686 |
|
|
2013
Q2 | $918K | Buy |
+15,027
| New | +$834K | 0.01% | 1439 |
|
Other funds holding NUS
PGCM
Comerica Bank's NUS Position: Q4 2025 in Review
Comerica Bank reduced its Nu Skin (NUS) stake by 1.3% in Q4 2025, selling an estimated $4.28K and leaving 31,814 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.
Comerica Bank first reported a position in NUS in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.24M in Q2 2018. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.
- Comerica Bank held 31,814 shares of Nu Skin worth $306K as of Q4 2025.
- Comerica Bank sold 414 Nu Skin shares in Q4 2025, an estimated $4.28K.
- Nu Skin made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2099 holding.
- Comerica Bank first reported a position in Nu Skin in Q2 2013 and has held it in 37 quarters since.
- Comerica Bank's Nu Skin position peaked at $3.24M in Q2 2018.
- 187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.